Literature DB >> 22026285

Serologic survey of humans for flavivirus West Nile in Southern Moravia (Czech Republic).

Zdenek Hubálek1, Bohumír Kríz, Jirí Halouzka.   

Abstract

A serosurvey for West Nile virus (WNV) was carried out in 525 persons, using a plaque-reduction neutralization microtest (PRNmicroT) with Vero cells and Egyptian topotype Eg-101 strain as test virus. The blood sera were collected in four South-Moravian districts (Hodonin 44 persons, Breclav 102 persons, Znojmo 170 persons, Jihlava 209 persons) of the Czech Republic in the years 1988 and 1989, and stored at -20 degrees C. Antibodies to WNV were detected in only three humans (0.6% seropositivity): one person each in the districts of Hodonin (2.3% persons positive), Breclav (1.0% positive) and Jihlava (0.5% positive), with the titres of 1:64, 1:32, and 1:32, respectively. All the three sera were negative for antibody to tick-borne encephalitis virus. The results indicate that activity of WNV in southern Moravia was very low before 1990.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22026285     DOI: 10.21101/cejph.a3635

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  3 in total

1.  Emergence of West Nile virus lineage 2 in Europe: Characteristics of the first seven cases of West Nile neuroinvasive disease in horses in Austria.

Authors:  Phebe de Heus; Jolanta Kolodziejek; Jeremy V Camp; Katharina Dimmel; Zoltán Bagó; Zdenek Hubálek; René van den Hoven; Jessika-M V Cavalleri; Norbert Nowotny
Journal:  Transbound Emerg Dis       Date:  2019-12-24       Impact factor: 5.005

Review 2.  History of Arbovirus Research in the Czech Republic.

Authors:  Zdenek Hubálek
Journal:  Viruses       Date:  2021-11-22       Impact factor: 5.048

3.  West Nile Virus and Tick-Borne Encephalitis Virus Are Endemic in Equids in Eastern Austria.

Authors:  Phebe de Heus; Jolanta Kolodziejek; Zdenĕk Hubálek; Katharina Dimmel; Victoria Racher; Norbert Nowotny; Jessika-M V Cavalleri
Journal:  Viruses       Date:  2021-09-19       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.